Our population-based glioblastoma study is unique regarding the spectrum of investigated parameters: it provides data on the prognostic impact of biological tumor characteristics (IDH, MGMT), the neurosurgical use of 5-ALA for intraoperative tumor visualization, and treatment modalities including extent of resection, postsurgical treatment, and treatment at relapse. This evidence concerns the gene IDH1 and glioblastoma.